US2016354463A1PendingUtilityA1

Allergen fragments

34
Assignee: BIOMAY AGPriority: Feb 13, 2007Filed: May 3, 2016Published: Dec 8, 2016
Est. expiryFeb 13, 2027(~0.6 yrs left)· nominal 20-yr term from priority
A61P 37/04A61P 37/08A61P 37/00A61K 39/36C07K 14/415G01N 2800/24G01N 33/6893
34
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention relates to a peptide derived from the ragweed pollen allergen Amb a (1) and comprising (6 to 50) amino acid residues and pharmaceutical preparations comprising said peptide and uses thereof.

Claims

exact text as granted — not AI-modified
1 . A ragweed pollen allergen Amb a 1 peptide consisting of the amino acid sequence of SEQ ID NO: 115 or variants thereof differing by one amino acid residue or comprising conservative changes. 
     
     
         2 . A pharmaceutical composition, comprising a peptide according to  claim 1 . 
     
     
         3 . The pharmaceutical composition of  claim 2 , further comprising at least one pharmaceutically acceptable adjuvant, excipient, or carrier.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.